Key facts
- It has raised $6.7M across 1 recorded rounds; the latest was Early Stage VC ($6.7M) in Dec 2024.
- Notable investors include M12, UPMC Enterprises, Healthworx.
- RAAPID has filed 1 Form D with the SEC, most recently Jan 2025 ($6.7M sold to 14 investors).
- Status: Privately Held (backing).
Investors
3- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for RAAPID
Funding rounds
1 roundsAbout RAAPID
Developer of a risk adjustment technology designed to empower organizations to deliver accurate risk scores through advanced AI tools. The company's technology provides flexible data exchange options and pushes valuable clinical insights to the point of care, reducing provider abrasion and supporting value-based care activities, enabling patients to get compliant and effective data capture at all stages of care.
- Sector
- Healthcare
- HQ
- Louisville, KY, United States
- Founded
- 2022
- Employees
- 75
- Website
- raapidinc.com/
- Ownership
- Privately Held (backing)
RAAPID doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RAAPID shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RAAPID in its N-PORT filings yet. We sweep new filings monthly.